IPO Trending
JFLLIFESME / NSEListed
JFL Life Sciences

JFL Life Sciences Limited, established in 2010, is a pharmaceutical company specializing in the manufacturing of a variety of medicines. Its product range includes dry powder injections (B-Lactam), tablets, capsules (B-Lactam and general), and oral rehydration solutions (ORS). The company follows a bulk sales strategy, supplying its products to pharmaceutical marketers and traders who then distribute them to customers. JFL has a strong presence across India and exports to 10 countries worldwide. Internationally, JFL supplies products to African, Middle Eastern, and CIS countries through merchant exporters. The company is also registered with the Ministries of Health (MOH) in Kenya, Nigeria, Yemen, Cambodia, and Myanmar for specific products, with additional registrations in Ukraine, Uzbekistan, and Kazakhstan. JFL operates two leased manufacturing units in Gujarat to produce its pharmaceutical products.

₹61 - ₹618.93x sub
GMP₹0
Est. Listing Price₹61

Subscription Status

8.93xTotal Demand
Updated 20 Oct 2026, 01:30 AM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date25 Aug 2022
Close Date30 Aug 2022
Listing Date08 Sep 2022
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About JFL Life Sciences IPO Subscription Demand

Live subscription status and bidding analysis for JFL Life Sciences (JFLLIFE) IPO. The issue is subscribed 8.93x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions